Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Results of a Phase I Study using Velcade (Bortezomib), Cladribine, and Rituximab (VCR) in treating Mantle Cell Lymphoma

Jeffrey J. Pu, MD PhD, W. Christopher Ehmann, MD, Jason Liao, PhD, Christine Capper, BSN, Michelle Levy, MD, David F. Claxton, MD, Witold B. Rybka, MD, Raymond J. Hohl, MD PhD, Elliot M. Epner, MD PhD

Blood (2016) 128 (22): 1792.

https://doi.org/10.1182/blood.V128.22.1792.1792

Published: 2016

Journal Articles

Combined Epigenetic and Immunotherapy For Newly Diagnosed Mantle Cell Lymphoma: Correlative Studies Suggest The Importance Of Enhanced ADCC, Mechanisms of Resistance and Cyclin D1 Nuclear Localization Genotype

Kamal Sharma, DO, Violetta V. Leshchenko, PhD, Zainul Hasanali, BS, August Stuart, MS, Sara Shimko, BS, Stephen E Spurgeon, MD, Samir Parekh, MD, Elliot M Epner, MD Phd

Blood (2013) 122 (21): 3063.

https://doi.org/10.1182/blood.V122.21.3063.3063

Published: 2013

Journal Articles

Overcoming Ibrutinib Resitance In Relapsed Chronic Lymphocytic Leukemia

Kamal Sharma, DO, August Stuart, MS, Elliot M Epner, MD, PhD, Thomas P. Loughran, Jr., MD

Blood (2013) 122 (21): 4891.

https://doi.org/10.1182/blood.V122.21.4891.4891

Published: 2013

Journal Articles

Establishment of a New Mantle Cell Lymphoma Cell Line That Has Epigenetically Silenced CD20 As a Resistance Mechanism in Vivo

August Stuart, BA, Kamal Sharma, DO, Sara Shimko, BS, Zainul Hasanali, BS, Elliot M Epner, MD, PhD

Blood (2012) 120 (21): 4619.

https://doi.org/10.1182/blood.V120.21.4619.4619

Published: 2012

Journal Articles

Vorinostat (SAHA), Cladribine, and Rituximab in Previously Untreated Mantle Cell Lymphoma: Updated Results From a Phase I/II Trial

Stephen E Spurgeon, MD, Kamal Sharma, DO, David F. Claxton, MD, Christopher W. Ehmann, MD, Carla Gallagher, PhD, Sara Shimko, BS, August Stewart, Samir Parekh, MD, Violetta V. Leshchenko, PhD, Yiyi Chen, PhD, Elliot M Epner, MD, PhD

Blood (2012) 120 (21): 3675.

https://doi.org/10.1182/blood.V120.21.3675.3675

Published: 2012

Journal Articles

Epigenetic Modulation of CD30 Gene Expression in Alemtuzumab Resistant T Cell Malignancy:Rationale and Efficacy of Brentuximab Vedotin.

Zainul Hasanali, BS, Kamal Sharma, DO, Sara Shimko, BS, August Stuart, BA, Elliot M Epner, MD, PhD

Blood (2012) 120 (21): 2454.

https://doi.org/10.1182/blood.V120.21.2454.2454

Published: 2012

Journal Articles

Epigenetic Modulation of Alemtuzumab Mediated Antileukemia Effects and Resistance in T- Cell Prolymphocytic Leukemia

Kamal Sharma, DO, Mithun Shah, MD, PhD, Zainul Hasanali, BA, Vikas Ghai, MD, Katie Broeg, BS, Sara Shimko, BS, August Stuart, BA, Elliot M Epner, MD, PhD, Thomas P. Loughran, Jr., M.D.

Blood (2011) 118 (21): 2440.

https://doi.org/10.1182/blood.V118.21.2440.2440

Published: 2011

Journal Articles

Crosstalk Between Cyclins D1 and D3 in Mantle Cell Level At the Transcriptional and Postranscriptional Levels

August Stuart, BA, Sara Shimko, BA, Elliot M Epner, MD, PhD

Blood (2011) 118 (21): 1373.

https://doi.org/10.1182/blood.V118.21.1373.1373

Published: 2011

Journal Articles

A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma

Stephen Spurgeon, MD, Andy I Chen, MD, PhD, Craig Okada, MD, PhD, Samir Parekh, MD, Violetta V. Leshchenko, PhD, Gundula Palmbach, Bashi Ratterree, RN, Nan Subbiah, Christine Capper, RN, Elliot M Epner, MD, PhD

Blood (2011) 118 (21): 441.

https://doi.org/10.1182/blood.V118.21.441.441

Published: 2011

Journal Articles

Combination Therapy with Cladribine, Vorinostat, and Ofatumumab Achieves Complete Hematologic Remission in Refractory Classical Hairy Cell Leukemia

Vikas Ghai, MD, Kamal Sharma, DO, Kamal K.S. Abbi, Sara Shimko, BS, Elliot M Epner, MD, PhD

Blood (2011) 118 (21): 4622.

https://doi.org/10.1182/blood.V118.21.4622.4622

Published: 2011

Journal Articles

Transvection Mediated by the Translocated Cyclin D1 Gene in Mantle Cell Lymphoma.

Elliot M. Epner, MD, PhD, Hui Liu, PhD, Jing Wang, PhD, Mathew Thayer, PhD

Blood (2007) 110 (11): 4156.

https://doi.org/10.1182/blood.V110.11.4156.4156

Published: 2007

Journal Articles

A Multi Center Trial of hyperCVAD+Rituxan in Patients with Newly Diagnosed Mantle Cell Lymphoma.

Elliot M. Epner, MD, PhD, Joseph Unger, PhD, Thomas Miller, MD, Lisa Rimzsa, PhD, Catherine Spier, MD, Michael Leblanc, PhD, Richard Fisher, MD

Blood (2007) 110 (11): 387.

https://doi.org/10.1182/blood.V110.11.387.387

Published: 2007

Journal Articles

CTCF and Nucleophosmin Participate in Long Distance Cyclin D1 Deregulation in Mantle Cell Lymphoma.

Elliot M. Epner, MD, PhD, Jing Huang, PhD, Hui Liu, PhD, Jin Wang, PhD, Shugiang Liang, PhD, William H. Fleming, MD, PhD

Blood (2007) 110 (11): 989.

https://doi.org/10.1182/blood.V110.11.989.989

Published: 2007

Journal Articles

Transallelic Effects at the Cyclin D1 Loci in Mantle Cell Lymphoma.

Elliot M. Epner, MD, Phd, Liu Hui, PhD, Wang Jin, PhD, Huang Jing, PhD, Clurman E. Bruce, MDPhD

Blood (2005) 106 (11): 2839.

https://doi.org/10.1182/blood.V106.11.2839.2839

Published: 2005

Journal Articles

Cooperative Silencing of Chicken ρ- and β H- Globin Gene Expression by Chicken β-Globin Regulatory Elements: Involvement of RNAi Mediated Repression.

Elliot M. Epner, MD, PhD, Jin Wang, PhD, Jing Huang, PhD

Blood (2005) 106 (11): 3627.

https://doi.org/10.1182/blood.V106.11.3627.3627

Published: 2005

Journal Articles

CTCF and Nucleophosmin Mediate Long Distance Cyclin D1 Deregulation in t(11;14) B Cell Malignancies.

Elliot M. Epner, MD, PhD, Jin Wang, PhD, Hui Liu, PhD, Bruce Clurman, MDPhD

Blood (2005) 106 (11): 742.

https://doi.org/10.1182/blood.V106.11.742.742

Published: 2005

Journal Articles

Cyclin D1 Deregulation in Mantle Cell Lymphoma: Tethering of the Cyclin D1 Promoter and 3′ Immunoglobin Enhancers by CTCF and Nucleophosmin.

Elliot M. Epner, MD PhD, Hui Liu, PhD, Wang Jin, PhD, Jing Huang, PhD, Craig R. Nichols, MD, Richard T. Maziarz, MD

Blood (2004) 104 (11): 1536.

https://doi.org/10.1182/blood.V104.11.1536.1536

Published: 2004

NARROW

The Results of a Phase I Study using Velcade (Bortezomib), Cladribine, and Rituximab (VCR) in treating Mantle Cell Lymphoma

Combined Epigenetic and Immunotherapy For Newly Diagnosed Mantle Cell Lymphoma: Correlative Studies Suggest The Importance Of Enhanced ADCC, Mechanisms of Resistance and Cyclin D1 Nuclear Localization Genotype

Overcoming Ibrutinib Resitance In Relapsed Chronic Lymphocytic Leukemia

Establishment of a New Mantle Cell Lymphoma Cell Line That Has Epigenetically Silenced CD20 As a Resistance Mechanism in Vivo

Vorinostat (SAHA), Cladribine, and Rituximab in Previously Untreated Mantle Cell Lymphoma: Updated Results From a Phase I/II Trial

Epigenetic Modulation of CD30 Gene Expression in Alemtuzumab Resistant T Cell Malignancy:Rationale and Efficacy of Brentuximab Vedotin.

Epigenetic Modulation of Alemtuzumab Mediated Antileukemia Effects and Resistance in T- Cell Prolymphocytic Leukemia

Crosstalk Between Cyclins D1 and D3 in Mantle Cell Level At the Transcriptional and Postranscriptional Levels

A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma

Combination Therapy with Cladribine, Vorinostat, and Ofatumumab Achieves Complete Hematologic Remission in Refractory Classical Hairy Cell Leukemia

Transvection Mediated by the Translocated Cyclin D1 Gene in Mantle Cell Lymphoma.

A Multi Center Trial of hyperCVAD+Rituxan in Patients with Newly Diagnosed Mantle Cell Lymphoma.

CTCF and Nucleophosmin Participate in Long Distance Cyclin D1 Deregulation in Mantle Cell Lymphoma.

Transallelic Effects at the Cyclin D1 Loci in Mantle Cell Lymphoma.

Cooperative Silencing of Chicken ρ- and β H- Globin Gene Expression by Chicken β-Globin Regulatory Elements: Involvement of RNAi Mediated Repression.

CTCF and Nucleophosmin Mediate Long Distance Cyclin D1 Deregulation in t(11;14) B Cell Malignancies.

Cyclin D1 Deregulation in Mantle Cell Lymphoma: Tethering of the Cyclin D1 Promoter and 3′ Immunoglobin Enhancers by CTCF and Nucleophosmin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only